Georgian Partners Experience MicroPort MedBot Toumai® with Lexaid Founder

On 14 September 2026, following hospital visits in Shanghai, Lexaid Founder Ms. Suky Ji (及淑芳)—also a Co-founder of MicroPort MedBot (HKEX: 2252)—accompanied Georgian cross-border medical partners to experience surgical-robotics technology at MicroPort MedBot.

Advanced equipment is often part of why families consider care in China, but overseas partners still need a clear line between technology showcases and real clinical admission. The stop gave guests a firsthand look at the Toumai® laparoscopic surgical robot console under the MEDBOT brand—while Lexaid reiterated that clinical indications and procedures remain with licensed hospital teams.

Hands-on view: Toumai® console experience with Lexaid Founder Ms. Suky Ji

Sitting at the surgeon console, guests could observe the training interface and the system layout used in laparoscopic robotic surgery demonstrations. Ms. Ji shared how Lexaid positions itself in the care journey: matching pathways, translating expectations, and coordinating travel and in-hospital logistics—so technology advantages become usable steps for families, not marketing claims alone.

Visit highlights

• Toumai® console experience — close look at MicroPort MedBot’s laparoscopic surgical robot workstation.
• Founder dual perspective — medical-technology insight plus cross-border patient-coordination practice.
• Clear boundaries — equipment observation is not a treatment promise; hospitals decide clinical eligibility.
• Series completion — together with Shanghai Yida Hospital and Shanghai Xiehua Brain Hospital, a three-stop Shanghai benchmark day for Georgian partners.

Lexaid will keep connecting overseas partners with China’s leading hospitals and compliant medtech ecosystems—building clearer, more trustworthy cross-border medical coordination around www.lexaidmed.com.

Consultation: WhatsApp +86 185 2131 5346 · Email [email protected]
Learn more: www.lexaidmed.com